DOCSLIB.ORG

The 2 Asia Medical Week

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The 2 Asia Medical Week SYNERGIZED INNOVATION & SUSTAINED EVOLUTION THE 2nd ASIA MEDICAL WEEK ASIAN MEDICAL INNOVATION & DEVELOPMENT FORUM 2019 Fudan Zhongshan International Oncology Summit & Annual Conference of Fudan Zhongshan Cancer Center Shanghai / Shenzhen Oct.19-21 2019 ACTIVITIES RECAP 2018 South Korea 2019 Statistics 11 4 4 1000+ 30 81% Sub-Forums Private Sessions Clinial Exchange Visit Attendees Countries & Regions Top Management Presidents, Vice-Presidents, CEOs, Directors or Officers from Governments, MOHs & Hospitals. Overseas Visitors Armenia Australia Bangladesh Belarus Brazil China Egypt France Greece India Indonesia Italy Japan Kazakhstan Kenya Malaysia Myanmar Northern Cyprus Pakistan Philippines Russia Singapore South Korea Sri Lanka Thailand Turkey Ukraine UK US Vietnam Launching Ceremony Dear Professors, We take a great pleasure in inviting you to the 2019 Asian Medical Week, which is held in Shanghai from October 19th to October 21st , 2019. Asia Medical Week is a prominent academic event for promoting medical communication and cooperation in the Asia-Pacific region. With the theme focusing on "Medical Innovation & Development", 2019 Asia Medical Week is dedicated to providing an effective communication platform for international healthcare community and industry to showcase China’s latest oncology, promote sharing for high-quality healthcare resources and advocate high-tech cooperation for modern medicine. Towards a vision of "Collaborative Innovation, Sustainable Progress", Fudan University Zhongshan Hospital and Fudan University Zhong Shan Hospital Cancer Center (FUZSCC) will host the 2019 Asian Medical Week - - Medical Innovation & Development Forum, featuring 2019 Fudan Zhongshan International Oncology Summit, in concurrent with the annual meeting of FUZSCC. To pace the internationalization and development of China healthcare system through in-depth communication and collaboration between Asia-Pacific countries, the program will focus on the newest advances in tumor management and establish “the Belt and Road” Oncology Alliance during the event. At that FAN Jia time, there will be thousands of clinical, diagnostic and nursing experts Executive Chairman of the Forum at home and abroad to discuss the overall management and the latest Academician of Chinese Academy of Sciences diagnosis and treatment progress of cancer prevention and treatment, President of Shanghai Zhongshan Hospital, Fudan University seeking a common future development of the medical community. In view of your outstanding achievement and influence in medical field, we hope that you can provide insights for the improvement of cancer prevention and give advice on the development of the discipline. We can expect the sweet-scented osmanthus blooming everywhere this autumn. We sincerely look forward to your cooperation for this grand event in Shanghai! Sincerely, 02 Host WANG Xin Secretary General, Committee of the CPC, Zhongshan Hospital, Fudan University China Opening Address Opening Address ZENG Yixin ZONG Ming Deputy Director, Deputy Mayor, National Health Commission, P.R.C. Shanghai Municipal Government China China Opening Address Opening Address FAN Jia Ivan STILIDI Director, Director, Zhongshan Hospital, Fudan University National Medical Research Center of Oncology named after N.N. Blokin, China Russian Federation Opening Address Opening Address JIAO Yang LI Zaiwen Director, Senior Vice President, Zhongshan Hospital, Fudan University Shenzhen Mindray BioMedical Electronics Co., Ltd. China China Fan Jia, Chinese Sciences Academician, Director of Zhongshan Hospital, Fudan University, pointed that-- “Asia Medical Week” has become a very important academic platform for medical exchange & collaboration in Asia-Pacific & the world. Experts and scholars from world-renowned hospitals had discussed in-depth on topics of cutting-edge technology, hospital construction, quality management, performance system & doctor-patient relationship with the theme focusing on “Medical Innovation & Development” in 2018. And this year, towards a vision of "Collaborative Innovation, Sustainable Progress", Fudan University Zhong Shan Hospital Cancer Center (FUZSCC) hosted the 2nd Asia Medical Week to execute “the Belt & Road” Initiative & “Healthy China” Initiative. Sub Forums VENUE VENUE VENUE VENUE VENUE VENUE Host A B C D E F ZHU Chouwen Vice President of Zhongshan Hospital, Fudan University China New Practice of Precise Tumor Advances in Cancer Radiotherapy Immunotherapy: from Melanoma to other Types LU Jiade Executive Vice President of Shanghai Proton Michele MAIO & Heavy Ion Center (SPHIC) Director, Tumor Immunization Center, Professor of Clinical Oncology of Fudan Siena University University School of Medicine Director of Oncology, Siena University Italy VENUE VENUE Master’s Forum Master’s Forum A2 A2 Molecular Typing of Liver New Approaches in Treatment Cancer of Hepatobiliary System Oncopathology Dhanpat JAIN Petrovsky VALERYEVICH Director, Section of Gastrointestinal & Liver Fellowship Program, Yale University Executive Director of Association of School of Medicine Oncologists of Russia Member of the American Society for USA Brachytherapy Russia Fedevation VENUE VENUE Zhongshan International Forum Zhongshan International Forum A3 on Digestive Tumors A3 on Digestive Tumors Current Status of Systemic Perioperative Treatment Therapy for Unresectable Strategy for Esophageal Cancer Colorectal Cancer in Japan TAN Lijie Kentaro YAMAZAKI Director of Thoracic/Esophageal Surgery Clinical Trial Coordination Unit Division of Dept. y Gastrointestinal Oncology Zhongshan Hospital, Fudan University Shizuoka Cancer Center China Japan VENUE VENUE Zhongshan International Forum Zhongshan International Forum A3 on Digestive Tumors A3 on Digestive Tumors VENUE VENUE VENUE VENUE VENUE VENUE Host A B C D E F LIU Tianshu Director of Oncology Department, Zhongshan Hospital, Fudan University China Minimally Invasive Surgical Progress of WHO & AJCC on Treatment of Early Thymoma Neuroendocrine Neoplasms Takashi SUDA Grace KIM Fujita Health University School of Medicine Vice Chair of Clinical Services Department of Pathology, Medical Director of Pathology Japan Services, University of Califonia San Francisco USA VENUE VENUE Forum on Forum on Hepatobiliary & Pancreatic Tumor C2 Mediastinal Tumor C3 and Immune Pathology AI & Tumor Immunotherapy The Surgery for Ovarian Cancer Patients with High Tumor Burden YEONG Poh Sheng Joe Group Leader, Institute of Molecular & ZHU Jianqing Cell Biology Chief Physician, Director of Gynecology & Research Pathologist, Anatomical Oncology Dept., Pathology Department, SGH Cancer Hospital of Chinese Academy of Singapore Science Zhejiang Cancer Hospital China VENUE VENUE Forum on Hepatobiliary & Forum on C3 Pancreatic Tumor and Immune Pathology D Gynecological Oncology Update & Controversy in Lobular Treatment of Cancer Pain Carcinoma in Situ of the Breast XU Bei Yunn-Yi CHEN Associate Chief Physician Oncology Department, Zhongshan Hospital, Professor, University of California San Fudan University Francisco (UCSF) Clinical Pathology, Step 4 Pathology School China of Medicine USA VENUE VENUE Forum on Forum on E Breast Tumor F2 Tumor Palliative and Nursing Private Sessions VENUE Host G HUANG Pengcheng Vice President of Domestic Sales & Marketing Department of Mindray Group China Opening Address Opening Address YANG Yong Jean-Marc DURRHEIME Marketing Director, Director of Biomedical International UIS Sales & Marketing Engineering Dept. Department of Mindray Group Centre Hospitalier de Haguenau China France VENUE VENUE Session on Session on G1 Ultrasound Application G1 Ultrasound Application Opening Address Opening Address Richard BARR Alexis KELEKIS Professor of Radiology at Ohio professor of diagnostic and Medical University interventional musculoskeletal radiology at the University of Athens USA Greec VENUE VENUE Session on Session on G1 Ultrasound Application G1 Ultrasound Application Opening Address Opening Address HUANG Pintong WANG Wenping Chief Physician Director of Ultrasound Director of the Department of Ultrasound, Medicine Department the Second Zhongshan Hospital, Fudan University Affiliated Hospital Zhejiang University School of Medicine China China VENUE VENUE Session on Session on G1 Ultrasound Application G1 Ultrasound Application VENUE Host G LI Weiping President of Renji Hospital, Shanghai Jiaotong University China Opening Address Opening Address YIN Luntao Alex Enriquez Vice President of Mindray Group ALEGRADO China President of ARC Oncology Group, Inc., Philippines VENUE VENUE Session on Session on G2 Comprehensive Topics G2 Comprehensive Topics The Impact of International Current Status, History and Cooperation in Child Liver Characteristics of Dialysis Transplantation Therapy in Japan Azura Binti MANSOR Tetsuya Yamada Deputy Director of Clinical Services (Surgical), Executive Managing Director, Kaikoukai University Malaya Medical Centre Healthcare Corporation Malaysia Japan VENUE VENUE Session on Session on G2 Comprehensive Topics G2 Comprehensive Topics Challenges in Delivery of Quality Healthcare Service & International Care in East Africa & Expanding Cooperation in South Asia Access to Healthcare through Efficiency Improvement & Cost Farooq Jamil Reduction Special Secratary Health, Khyber Pakhtunkhwa Province, MOH Shawn Bolouki Pakistan CEO, Agakhan University Hospital, Kenya VENUE VENUE Session on Session on G2 Comprehensive Topics G2 Comprehensive Topics Clinical Exchange Visit VENUE VENUE H1 H2 Zhongshan Hosptial Renji Hosptial Zhongshan Hospital, Fudan
Load more

Recommended publications
  • Name of Recognized Medical Schools (Foreign)
    1 Name of Recognized Medical Schools (Foreign) Expired AUSTRALIA 1 School of Medicine, Faculty of Heath, University of Tasmania, Tasmania, Australia (5 years Program) 9 Jan Main Affiliated Hospitals 2021 1. Royal H obart Hospital 2. Launceston Gen Hospital 3. NWest Region Hospital 2 Melbourne Medical School, University of Melbourne, Victoria, Australia (4 years Program) 1 Mar Main Affiliated Hospitals 2022 1. St. Vincent’s Public Hospital 2. Epworth Hospital Richmond 3. Austin Health Hospital 4. Bendigo Hospital 5. Western Health (Sunshine, Footscray & Williamstown) 6. Royal Melbourne Hospital Affiliated Hospitals 1. Pater MacCallum Cancer Centre 2. Epworth Hospital Freemasons 3. The Royal Women’s Hospital 4. Mercy Hospital for Women 5. The Northern Hospital 6. Goulburn Valley Health 7. Northeast Health 8. Royal Children’s Hospital 3 School of Medicine and Public Health, University of Newcastle, New South Wales, Australia (5 years Program) 3 May Main Affiliated Hospitals 2022 1.Gosford School 2. John Hunter Hospital Affiliated Hospitals 1. Wyong Hospital 2. Calvary Mater Hospital 3. Belmont Hospital 4. Maitland Hospital 5. Manning Base Hospital & University of Newcastle Department of Rural Health 6. Tamworth Hospital 7. Armidale Hospital 4 Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia (4 and 5 years Program) 8 Nov Main Affiliated Hospitals 1. Eastern Health Clinical School: EHCS 5 Hospitals 2022 2. Southern School for Clinical Sciences: SCS 5 Hospitals 3. Central Clinical School จ ำนวน 6 Hospitals 4. School of Rural Health จ ำนวน 7 Hospital 5 Sydney School of Medicine (Sydney Medical School), Faculty of Medicine and Health, University of Sydney, Australia 12 Dec (4 years Program) 2023 2 Main Affiliated Hospitals 1.
    [Show full text]
  • Decreased Serum Ceruloplasmin Levels Characteristically Aggravate Nigral Iron Deposition in Parkinson’S Disease Downloaded From
    doi:10.1093/brain/awq319 Brain 2011: 134; 50–58 | 50 BRAIN A JOURNAL OF NEUROLOGY Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease Downloaded from Lirong Jin,1,* Jian Wang,2,* Lei Zhao,1 Hang Jin,2 Guoqiang Fei,1 Yuwen Zhang,1 Mengsu Zeng2 and Chunjiu Zhong1,3,4 brain.oxfordjournals.org 1 Department of Neurology, Zhongshan Hospital and Shanghai Medical College, Fudan University, Shanghai, China 2 Department of Radiology, Zhongshan Hospital and Shanghai Medical College, Fudan University, Shanghia, China 3 State Key Laboratory of Medical Neurobiology, Shanghai Medical College, Fudan University, Shanghai, China 4 Institutes of Brain Science, Fudan University, Shanghai, China *These authors contributed equally to this work. Correspondence to: Chunjiu Zhong, MD, PhD, at Main Library L610 Lawrence Livermore Nat Lab on January 23, 2011 Department of Neurology, Zhongshan Hospital and Shanghai Medical College, Fudan University, Shanghai, China E-mail: [email protected] Correspondence may also be addressed to: Mengsu Zeng, MD, PhD, E-mail: [email protected] In vivo and post-mortem studies have demonstrated that increased nigral iron content in patients with Parkinson’s disease is a prominent pathophysiological feature. However, the mechanism and risk factors associated with nigral iron deposition in pa- tients with Parkinson’s disease have not been identified and represent a key challenge in understanding its pathogenesis and for its diagnosis. In this study, we assessed iron levels in patients with Parkinson’s disease and in age- and gender-matched control subjects by measuring phase values using magnetic resonance based susceptibility-weighted phase imaging in a 3T magnetic resonance system.
    [Show full text]
  • Differences in Treatment Effect Size Between Progression-Free Survival
    2572 Original Article Differences in treatment effect size between progression-free survival and overall survival in anti-PD-1/PD-L1 inhibitors-based trials in advanced NSCLC: a systematic review and meta-analysis Zhirui Zhou1#, Shengxiang Ren2#, Lingxiao Chen3, Caicun Zhou2, Tao Jiang2,4 1Radiation Oncology Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China; 2Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China; 3Institute of Bone and Joint Research, Kolling Institute, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia; 4Department of Pulmonary Medicine, Shanghai Respiratory Research Institute, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China Contributions: (I) Conception and design: T Jiang, S Ren, C Zhou; (II) Administrative support: T Jiang, S Ren, C Zhou; (III) Provision of study materials or patients: T Jiang, S Ren, C Zhou; (IV) Collection and assembly of data: T Jiang, Z Zhou, L Chen; (V) Data analysis and interpretation: T Jiang, Z Zhou, L Chen; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Tao Jiang, PhD. Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, No. 507, Zheng Min Road, Shanghai 200433, China; Department of Pulmonary Medicine, Shanghai Respiratory Research Institute, Zhongshan Hospital Affiliated to Fudan University, No. 180, Fenglin Road, Shanghai 200032, China. Email: [email protected]. Background: To investigate the differences in treatment effect sizes between progression-free survival (PFS) and overall survival (OS) in advanced non-small cell lung cancer (NSCLC) treated with programmed cell death 1 (PD-1) and its ligand (PD-L1) blockade-based treatments.
    [Show full text]
  • Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer’S Disease
    RESEARCH ARTICLE Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease Xiaoli Pan1,2☯, Shaoming Sang1,2☯, Guoqiang Fei1, Lirong Jin1, Huimin Liu2, Zhiliang Wang3, Hui Wang3, Chunjiu Zhong1,2* 1 Department of Neurology, Zhongshan Hospital & Shanghai Medical College, Fudan University, Shanghai, China, 2 State Key Laboratory of Medical Neurobiology, Institutes of Brain Science & Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, China, 3 Regional Health Service Center of a11111 Xujiahui, Xuhui District, Shanghai, China ☯ These authors contributed equally to this work. * [email protected] Abstract OPEN ACCESS Citation: Pan X, Sang S, Fei G, Jin L, Liu H, Wang Z, et al. (2017) Enhanced Activities of Blood Background Thiamine Diphosphatase and Monophosphatase in Thiamine metabolites and activities of thiamine-dependent enzymes are impaired in Alzhei- Alzheimer's Disease. PLoS ONE 12(1): e0167273. mer's disease (AD). doi:10.1371/journal.pone.0167273 Editor: Marie-Claude Potier, Institut du cerveau et de la moelle epiniere, FRANCE Objective Received: April 17, 2016 To clarify the mechanism for the reduction of thiamine diphosphate (TDP), an active form of Accepted: November 12, 2016 thiamine and critical coenzyme of glucose metabolism, in AD. Published: January 6, 2017 Copyright: © 2017 Pan et al. This is an open access Methods article distributed under the terms of the Creative Forty-five AD patients clinically diagnosed and 38 age- and gender-matched control sub- Commons Attribution License, which permits unrestricted use, distribution, and reproduction in jects without dementia were voluntarily recruited. The contents of blood TDP, thiamine any medium, provided the original author and monophosphate (TMP), and thiamine, as well as the activities of thiamine diphosphatase source are credited.
    [Show full text]
  • International Students Guide Book Siping Campus English Version 1.Bank of Communication(交通银行) Add：41 Zhangwu Rd
    International Students Guide Book Siping Campus English Version 1 International Students Guide Book Siping Campus English Version Foreword Hello! Welcome to Tongji University! We wrote this guide book for you to help you with your life on campus and even in Shanghai. It contains some useful information that you may need in your study and daily life. Hope it can really do some help and wish you enjoy your life here! Group member： Ding Weiling (School of Political Science & International Relations) Dai Haocheng (College of Electronics & Information Engineering) Yu Zhenghao (College of Design & Innovation) Zhang Pei (Law school) April. 2017 2 International Students Guide Book Siping Campus English Version Contents First Arrived in Shanghai Overview of Shanghai 6 Overview of Tongji University 6 Legal Residence 7 Campus Life Student ID Card 15 Study 17 Dining 23 Medical Care 25 Network Communication 27 Traffic 30 Sports 32 School Stores & Shops 34 Activities 35 Useful Apps 36 Around the Campus Public Transportation 39 Banking 43 Shopping & Recreation 45 Campus Map 48 3 International Students Guide Book Siping Campus English Version Contents for Important Pictures Temporary Accommodation 13 Pharmacy around the Campus 27 Metro Stations around the Campus 40 Shanghai Metro Map 41 Bus Stations around the Campus 42 Banks & ATMs around the Campus 44 Campus Map 48 4 International Students Guide Book Siping Campus English Version First Arrived in Shanghai Overview of Shanghai 6 Overview of Tongji University 6 Legal Residence 7 5 International Students Guide Book Siping Campus English Version Overview of Shanghai Shanghai, once a humble fishing village, is now the economic, financial, trade and shipping center of China.
    [Show full text]
  • Cross-Culture Research for Developing WHO Self-Assessment
    Cross-Culture Research for Developing (Chinese version) WHO Self-Assessment tool for Health Promotion in Hospital Objectives Through cross-culture research to develop a Chinese version WHO self-assessment tool for Health Promotion in Hospital; Explore a high effective health care service model through developing health promotion in hospital; Discuss the strategies for HPH development in undeveloped region. Context Why the different conditions and resources makes the similar health promotion result between China and U.S Total expenditure on health per 83 The Unite State capita (Intl $, WHO,2006) Canada 6714 80 China 78 75 75 3672 72 342 Female Male The Unite Canada China Life expectancy at State birth(years) What are the differences between China and Unite State for developing HPH China The Unite State 1. Poor HPH condition Excellent HPH condition and and resource resource 2. Poor medical service Advanced medical service management system management system 3. Serious shortage of Excellent health service health service resource support system and resource 4. Poor public health developing condition Advanced public health and resource developing condition and resource What are the different HPH developing conditions between China and the Unite State China The Unite State Developed Country 1. Undeveloped country, Gross national income Gross national income per per capita (PPP capita (PPP international international $): 4,660 $): 44,070 2. 1.3billion population 0.3billion population 3. Polluted environment Healthy environment The different
    [Show full text]
  • The Cost of Alzheimer's Disease in China and Re-Estimation of Costs Worldwide
    Alzheimer’s & Dementia 14 (2018) 483-491 Featured Article The cost of Alzheimer’s disease in China and re-estimation of costs worldwide Jianping Jiaa,b,c,d,e,*, Cuibai Weia,*, Shuoqi Chena, Fangyu Lia, Yi Tanga, Wei Qina, Lina Zhaoa, Hongmei Jina, Hui Xua, Fen Wanga, Aihong Zhoua, Xiumei Zuoa, Liyong Wua, Ying Hana, Yue Hana, Liyuan Huanga, Qi Wanga, Dan Lia, Changbiao Chua, Lu Shia, Min Gonga, Yifeng Duf, Jiewen Zhangg, Junjian Zhangh, Chunkui Zhoui, Jihui Lvj, Yang Lvk, Haiqun Xiel, Yong Jim, Fang Lin, Enyan Yuo, Benyan Luop, Yanjiang Wangq, Shanshan Yangr, Qiumin Qus, Qihao Guot, Furu Liangu, Jintao Zhangv, Lan Tanw, Lu Shenx, Kunnan Zhangy, Jinbiao Zhangz, Dantao Pengaa, Muni Tangab, Peiyuan Lvac, Boyan Fangad, Lan Chuae, Longfei Jiaaf, Serge Gauthierag,* aDepartment of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China bBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China cCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China dKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China eNational Clinical Research Center for Geriatric Disorders, Beijing, China fDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, China gDepartment of Neurology, Henan Provincial People’s Hospital, Zhengzhou, China hDepartment of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, China iDepartment of Neurology, The First Teaching Hospital of Jilin University, Changchun, China jDementia Unit, Beijing Geriatric Hospital, Beijing,
    [Show full text]
  • Shanghai Guide
    “YOUR NAME HERE” …and your logo here. We hope you find this guide useful. If you wish to put your company’s name on it and publish we have a number of options for you. Please contact us at [email protected] “Committed to making you feel at home” Shanghai Guide For any specific information or enquires, please contact us Your address here E-mail: [email protected] Website: http://www.wwwaldron.com “YOUR NAME HERE” CONTACT [email protected] FOR MORE INFO. Welcome to Shanghai “YOUR NAME HERE” extends its most sincere welcome to you and to the members of your family who may be accompanying you on your assignment to Shanghai. Leaving home, family and friends behind to move to a new and perhaps completely unfamiliar place can be a difficult experience. It can however, be an exciting and rewarding time - new experiences and acquaintances await you. We in “YOUR NAME HERE” are here to guide and assist you through each and every step of your relocation to ensure a smooth transition to the new life that awaits you in Shanghai. This Relocation Guidebook has been developed as a useful and informative tool to provide answers to many of the questions that you and your family may have as you begin the resettlement process. We have included different sections including topics like housing, medicals, schools, transportation, etc. We have also included many places for food and drink, recreation, shopping, and weekend activities. This guidebook has been carefully prepared to give you all the information and more that you may ever need to help you settle into the Shanghai way of life.
    [Show full text]
  • Gastrointestinal (Colorectal and Anal)
    GASTROINTESTINAL CANCER—COLORECTAL AND ANAL 3500 Oral Abstract Session Final overall survival for the phase III KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC). Thierry Andre, Kai-Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis J. A. Punt, Denis Michel Smith, Rocio Garcia-Carbonero, Julia Alcaide, Peter Gibbs, Christelle De La Fouchardiere, Fernando Rivera, Elena Elez, Johanna C. Bendell, Dung T. Le, Takayuki Yoshino, Wen Yan Zhong, David R. Fogelman, Patricia Marinello, Luis A. Diaz; Sorbonne Universite� and Ho^pital- Saint Antoine, Paris, France; University College Hospital, NHS Foundation Trust, London, United King- dom; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Herlev and Gentofte Hospital, Herlev, Denmark; University Hospital of Southern Denmark, Vejle, Denmark; Depart- ment of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, Netherlands; Bordeaux University Hospital, Bordeaux, France; Hospital Universitario 12 de Octubre, Imas12, CNIO, UCM, Madrid, Spain; Hospital Regional Universitario de Malaga, Ma�laga, Spain; Western Health, St. Al- bans, Australia; Centre Le�on Be�rard, Lyon, France; Hospital Universitario Marque�s de Valdecilla, IDIV- AL, Santander, Spain; Vall dHebron Institute of Oncology, Barcelona, Spain; Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, TN; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; National Cancer Center Hospital East, Kashiwa, Japan; MSD China, Shanghai, China; Merck & Co., Inc., Kenilworth, NJ; Memorial Sloan Kettering Cancer Center, New York, NY Background: In the phase III, randomized open-label KEYNOTE-177 (NCT02563002) study 1L pem- brolizumab (pembro) versus chemotherapy (chemo) provided superior progression-free survival (PFS) at second interim analysis (IA2) in patients (pts) with MSI-H/dMMR mCRC.
    [Show full text]
  • Honor Rolls of Best Hospitals in China Released
    News Page 1 of 23 Honor rolls of best hospitals in China released Luna Young, Molly J. Wang Editorial Office,Journal of Hospital Management and Health Policy, Nanjing 210000, China Correspondence to: Molly J. Wang, Senior Editor. Editorial Office, Journal of Hospital Management and Health Policy, Nanjing 210000, China. Email: [email protected]. Received: 24 November 2017; Accepted: 03 December 2017; Published: 08 December 2017. doi: 10.21037/jhmhp.2017.12.01 View this article at: http://dx.doi.org/10.21037/jhmhp.2017.12.01 On November 11, 2017, the Honor Roll of the Best Best Comprehensive Hospitals in 2016. Comprehensive Hospitals in 2016 has been released by the In the meantime, the Honor Roll of Best Hospitals of Hospital Management Institute, Fudan University, China. Specialties in 2016 has been unveiled as well. Notably, The Honor Roll recognizes 100 hospitals for their altogether top 10 hospitals are selected in each of these exceptional comprehensive abilities where reputation of 37 specialties. The specialties range from Pathology, specialties and scientific research ability are among the Radiology, Pulmonology, Stomatology, Urology and factors predominantly weighed. Psychiatry and others with a rather comprehensive As usual, Peking Union Medical College Hospital, coverage on our daily needs. With no doubt, Peking Union West China Hospital of Sichuan University and General Medical College Hospital, West China Hospital of Sichuan Hospital of the People’s Liberation Army easily made University and General Hospital of the People’s Liberation the list, respectively ranking the top 3. Moreover, there Army, the top 3 comprehensive hospitals, are leading the are several hospitals rising greatly in the list, such as most entries of the specialties among the list.
    [Show full text]
  • Famous Hospitals in Shanghai City
    Famous Hospitals in Shanghai City Franco Naccarella Medical service system and pertinent bureau • There are four medical service systems in Shanghai. • They are Fu Dan University, Shanghai Jiao Tong University, Tong Jing University, Shanghai Traditional Chinese Medical School • Shanghai Bureau of health make the rule of hearth care and supervise all the hospitals attached to their university. Top Ten Hospital Fudan University • Zhongshan Hospital • Huashan Hospital Shanghai Jiao Tong University • First People’s Hospital • Sixth People’s Hospital • Renji Hospital • Ruijin Hospital • Xinhua Hospital • Nineth People’s Hospital Second Military Medical University • Changhai Hospital • Changzheng Hospital Zhongshan hospital Zhongshan hospital • Zhongshan Hospital was founded in 1936 in commemoration of the late Dr. Sun Yat- sen. It is a leading hospital in China and was awarded "The Best 100 Hospitals" in 1999 • The discipline of Zhongshan Hospital is Prudent, Practicality, Unity and Offering Zhongshan hospital www.zs-hospital.sh.cn • Cardiology, Hepatology,Nephrology and Respiratory diseases are their leading subject • Cardiology research institute is well known in the world. They performed the first cardiac catheter examination in China Zhongshan hospital • Cardiology department is the largest in Shanghai area. They have three catheter room, non-invasive cardiac exam center including treadmill exercise test, tilt table test, holter monitor, ABPM and advanced Echo center. • EP center have sophisticated EP console. They own CARTO-XP 3 dimension electroanatomy mapping equipment Zhongshan hospital • Their emergency PCI number is the largest in Shanghai area, about 400 cases for one year, and more than 1000 cases of selective PCI cases every year • The cardiolog department is also well known for myocardiopathy and myocarditis research • They are number of national qualified clinical medicine trial base and national EP training base Zhongshan hospital • The chief of cardiolgy is prof.
    [Show full text]
  • A Time-Series Panel Study
    Science of the Total Environment 619–620 (2018) 360–365 Contents lists available at ScienceDirect Science of the Total Environment journal homepage: www.elsevier.com/locate/scitotenv Effects of ambient temperature on lung function in patients with chronic obstructive pulmonary disease: A time-series panel study Zhijing Lin a,1, Yutong Gu b,1,CongLiua,YuanlinSongb, Chunxue Bai b,RenjieChena,c,⁎, Shujing Chen b,⁎⁎,HaidongKana a School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and Key Lab of Health Technology Assessment of the Ministry of Health, Fudan University, Shanghai 200032, China b Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China c Shanghai Key Laboratory of Meteorology and Health, Shanghai 200030, China HIGHLIGHTS GRAPHICAL ABSTRACT • This is a time-series panel study with in- tensive daily lung function measure- ments. • The associations between daily temper- ature and PEF were inverted U–shaped. • Both low and high temperatures were significantly associated with reduced PEF. • No apparent associations were observed for temperature and FEV1. article info abstract Article history: Background: Limited evidence concerns the associations between ambient temperature and lung function and Received 27 April 2017 the results are mixed. Received in revised form 3 November 2017 Objective: To evaluate the associations between temperature variations and daily fluctuations in pulmonary func- Accepted 3 November 2017 tion in chronic obstructive pulmonary disease (COPD) patients. Available online xxxx Methods: We designed a time-series panel study of 28 male urban COPD patients with repeated daily lung func- tion measurements from December 2012 to May 2013 in Shanghai, China.
    [Show full text]